Hexadecanamide,N-[(1R,2S)-1-[(b-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,rel- (9CI) (108392-00-3)

Identification
Name:	Hexadecanamide,N-[(1R,2S)-1-[(b-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,rel- (9CI)
CAS:	108392-00-3
Molecular Formula:	C40H79 N O8
Molecular Weight:	702.06
InChI:	InChI=1/C40H79NO8/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(43)33(32-48-40-39(47)38(46)37(45)35(31-42)49-40)41-36(44)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h33-35,37-40,42-43,45-47H,3-32H2,1-2H3,(H,41,44)
Molecular Structure:
Properties
Flash Point:	459.3°C
Boiling Point:	835.8°C at 760 mmHg
Density:	1.05g/cm³
Refractive index:	1.51
Flash Point:	459.3°C
Storage Temperature:	−20°C
Safety Data

Other Product

Tetracosanamide,N-[1-[(b-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,(R*,S*)- (9CI)
Tetradecanamide,N-[(1S,2R)-1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-
Tetracosanamide,N-[(1S,2R)-1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-
Hexadecanamide,N-[1-[[(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)oxy]methyl]-2-hydroxyheptadecyl]-,(R*,S*)- (9CI)
Tetradecanamide,N-[(1S,2R)-1-[(b-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-
Tetracosanamide,N-[(1S,2R)-1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-2-hydroxy-,(2R)-
Tetradecanamide,N-[(1R,2S)-1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxypentadecyl]-
Hexadecanamide,N-[(1S,2S,3R)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxyheneicosyl]-2-hydroxy-, (2R)-(9CI)
Octadecanamide,N-[1-[[(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)oxy]methyl]-2-hydroxyheptadecyl]-,(R*,S*)- (9CI)
Tetradecanamide,N-[(1R,2R)-1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxypentadecyl]-
Tetradecanamide,N-[(1S,2S)-1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxypentadecyl]-
Hexadecanamide,N-[(1S,2S,3R,12Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-12-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Hexadecanamide,N-[(1S,2S,3R,8Z)-1-[(b-D-glucopyranosyloxy)methyl]-2,3-dihydroxy-8-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Tetracosanamide,N-[1-[(b-D-galactopyranosyloxy)methyl]-2-(sulfooxy)-3-heptadecenyl]-2-(sulfooxy)-(9CI)
Octadecanamide,N-[(1S,2R)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxyheptadecyl]-2-hydroxy-,(2R)-
Tetradecanamide,N-[(1S,2R)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxyheptadecyl]-
Octadecanamide, N-[1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,DL-erythro- (8CI)
15-Tetracosenamide,N-[(1S,2S,3R,5E)-1-[(b-D-galactopyranosyloxy)methyl]-2,3-dihydroxy-5-heptadecenyl]-2-hydroxy-,(2R,15Z)- (9CI)
Hexadecanamide,N-[(1S,2S,3R,12Z)-1-[[(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)oxy]methyl]-2,3-dihydroxy-12-heneicosenyl]-2-hydroxy-,(2R)- (9CI)
Tetradecanamide,N-[(1S,2R)-1-[(a-D-glucopyranosyloxy)methyl]-2-hydroxyheptadecyl]-